BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 29713986)

  • 1. Point-Counterpoint: Screening and Surveillance for Barrett's Esophagus, Is It Worthwhile?
    Otaki F; Iyer PG
    Dig Dis Sci; 2018 Aug; 63(8):2081-2093. PubMed ID: 29713986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?
    Inadomi JM; Saxena N
    Dig Dis Sci; 2018 Aug; 63(8):2094-2104. PubMed ID: 29948571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening for adenocarcinoma in Barrett's esophagus: yes or no, when and how?].
    Sostres C; Lacarta P; Lanas A
    Gastroenterol Hepatol; 2013 Oct; 36(8):520-6. PubMed ID: 23453559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Screening Tests for Barrett's Esophagus.
    Codipilly DC; Iyer PG
    Curr Gastroenterol Rep; 2019 Jul; 21(9):42. PubMed ID: 31346777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of cancer risk in Barrett's esophagus.
    Tan A; Macrae F
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1485-92. PubMed ID: 21592226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.
    Kamboj AK; Katzka DA; Iyer PG
    Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):27-41. PubMed ID: 33213798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study.
    Visrodia K; Iyer PG; Schleck CD; Zinsmeister AR; Katzka DA
    Dig Dis Sci; 2016 Jan; 61(1):158-67. PubMed ID: 25956705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Barrett's esophagus: an update].
    González N; Parra-Blanco A; Cohen H
    Acta Gastroenterol Latinoam; 2012 Dec; 42(4):333-47. PubMed ID: 23383529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal adenocarcinoma and Barrett's esophagus.
    Sayana H; Wani S; Sharma P
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):157-69. PubMed ID: 17557044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's esophagus surveillance: When, how often, does it work?
    Katona BW; Falk GW
    Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):9-24. PubMed ID: 21112494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of patients with long-segment Barrett's esophagus: A multicenter prospective cohort study in Japan.
    Matsuhashi N; Sakai E; Ohata K; Ishimura N; Fujisaki J; Shimizu T; Iijima K; Koike T; Endo T; Kikuchi T; Inayoshi T; Amano Y; Furuta T; Haruma K; Kinoshita Y
    J Gastroenterol Hepatol; 2017 Feb; 32(2):409-414. PubMed ID: 27416773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to get the most out of costly Barrett's oesophagus surveillance.
    Braden B; Jones-Morris E
    Dig Liver Dis; 2018 Sep; 50(9):871-877. PubMed ID: 29730158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who Deserves Endoscopic Screening for Esophageal Neoplasia?
    Blevins CH; Iyer PG
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):365-378. PubMed ID: 28577762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.
    Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Should We Report Endoscopic Results in Patient's with Barrett's Esophagus?
    Gorrepati VS; Sharma P
    Dig Dis Sci; 2018 Aug; 63(8):2115-2121. PubMed ID: 29675664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients.
    Peters JH; Clark GW; Ireland AP; Chandrasoma P; Smyrk TC; DeMeester TR
    J Thorac Cardiovasc Surg; 1994 Nov; 108(5):813-21; discussion 821-2. PubMed ID: 7967662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk for esophageal neoplasia in Barrett's esophagus patients with mucosal changes indefinite for dysplasia.
    Horvath B; Singh P; Xie H; Thota PN; Allende DS; Pai RK; Patil DT; Plesec TP; Goldblum JR; Liu X
    J Gastroenterol Hepatol; 2015 Feb; 30(2):262-7. PubMed ID: 25087917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma.
    Grant KS; DeMeester SR; Kreger V; Oh D; Hagen JA; Chandrasoma P; DeMeester TR
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):31-7. PubMed ID: 23312980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal Adenocarcinoma: Screening, Surveillance, and Management.
    Mansour NM; Groth SS; Anandasabapathy S
    Annu Rev Med; 2017 Jan; 68():213-227. PubMed ID: 27618753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.